Results 141 to 150 of about 669,583 (341)

Platelet Uptake of Octopamine and Norepinephrine in Hepatic Encephalopathy

, 1977
Antonio Morelli, Margaret Frintzilas, David S. Zimmon   +2 more
openalex   +1 more source

Unstable Recompensation: An Intermediate Subtype in Patients With HBV‐Related Decompensated Cirrhosis

Alimentary Pharmacology &Therapeutics, EarlyView.
Recompensation is a heterogeneous and dynamic state in HBV‐related decompensated cirrhosis; The prognosis for patients with unstable recompensation was found to be worse compared to those with stable recompensation, but still better than patients without recompensation; Subclassification of recompensation has significant implications for prognosis and ...
Shuai Xia, Zhiying He, Xiaoning Wu, Zhongjie Hu, Chunqing Zhang, Yanqin Hao, Yongfeng Yang, Yan Huang, Wei Rao, Xiaoqian Xu, Xinyu Zhao, Jialing Zhou, Yameng Sun, Shuyan Chen, Luqi Tang, Xiaojuan Ou, Xinyan Zhao, Jidong Jia, Bingqiong Wang, Hong You   +19 more
wiley   +1 more source

HEMODIALYSIS AGAINST ACTIVATED CHARCOAL SUSPENSION AS A TREATMENT OF HEPATIC ENCEPHALOPATHY

, 1977
George E. Merino, Thomas Jetzer, T. J. Buselmeier, J. S. Najarian   +3 more
openalex   +1 more source

Animal versus vegetable protein diet in hepatic encephalopathy [PDF]

, 1993
Harold O. Conn
openalex   +1 more source

Acute onset neurological deficits and hypocalcaemia associated with nutritional secondary hyperparathyroidism in three juvenile servals (Leptailurus serval)

Australian Veterinary Journal, EarlyView.
Nutritional secondary hyperparathyroidism is a metabolic disorder caused by an imbalance in calcium homeostasis and is typically associated with the feeding of a calcium‐deficient diet. Nutritional secondary hyperparathyroidism has been reported in domestic species, including cats and dogs, as well as captive carnivores and wildlife including lions ...
JL Austen, JW Wheelahan, J O'Dwyer, S Beths, NL Rourke, BR Gardner   +5 more
wiley   +1 more source

Subclinical hepatic encephalopathy: Detection, prevalence, and relationship to nitrogen metabolism

, 1978
Layton F. Rikkers, Paul G. Jenko, Daniel Rudman, David Freides   +3 more
openalex   +1 more source

Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry

Clinical and Experimental Neuroimmunology, EarlyView.
ABSTRACT Objective The complement component 5 inhibitor therapies (C5ITs) eculizumab and ravulizumab are approved for the treatment of generalized myasthenia gravis (gMG). We evaluated the real‐world effectiveness and safety of eculizumab and ravulizumab in patients with gMG with or without prior intravenous immunoglobulin (IVIg) or plasma exchange ...
Akiyuki Uzawa, Ema Rodrigues, Hiroyuki Murai   +2 more
wiley   +1 more source

Clinical and Splenoportographic Studies on 6 Cases with Repeating Hepatic Encephalopathy

, 1978
Masatake Yasumoto, Atsushi Toyonaga, Kengo Ikeda, S Sawada, Hisaaki KAJI, T. Fujimi, Ei Sasaki, Tetsuya YUDA, Yoshihiko MITSUTAKE, Kazuo Fukuda, Masaki HIRAYAMA, Hiroshi Fukuyama, T Satomi, Kyuichi Tanikawa   +13 more
openalex   +2 more sources

Cerebral Ammonia Metabolism in Patients with Severe Liver Disease and Minimal Hepatic Encephalopathy [PDF]

, 1991
Alan H. Lockwood, Eddy W. H. Yap, Wai‐Hoi Wong   +2 more
openalex   +1 more source

Branched‐chain amino acids and all‐cause mortality in patients with liver cirrhosis, and the onset of diabetes in liver transplant recipients

European Journal of Clinical Investigation, EarlyView.
Our study demonstrates that total BCAA levels increase following liver transplantation. In patients with cirrhosis, higher total BCAA levels are associated with a reduced risk of all‐cause mortality. However, while this association is not observed in liver transplant recipients, elevated total BCAA levels are strongly linked to an increased risk of new‐
Yakun Li, Mateo Chvatal‐Medina, Maria Camila Trillos‐Almanza, Margery A. Connelly, Han Moshage, Stephan J. L. Bakker, Vincent E. de Meijer, Hans Blokzijl, Robin P. F. Dullaart, TransplantLines Investigators   +9 more
wiley   +1 more source